oncology focus drives stock growth amid acquisitions By Investing.com
McKesson Corporation (NYSE:), a leading healthcare services and information technology company with a market capitalization of $73.54 billion, has been making significant strides in the healthcare sector, particularly in its oncology and biopharma services. The company’s recent performance and strategic moves have caught the attention of analysts and investors alike, with seven analysts recently revising their earnings estimates upward according to InvestingPro data, prompting a closer look at its potential for sustained growth and market leadership.
Strong Performance in US Pharma Segment
McKesson’s US Pharma segment has been a key driver of the company’s recent success. In the second quarter of fiscal year 2025, the segment’s…
